Full Text:
<1628>
CLC number: R764.4
On-line Access: 2019-01-22
Received: 2019-01-16
Revision Accepted: 2019-01-18
Crosschecked: 2019-01-18
Cited: 0
Clicked: 4413
Frontiers in auditory bioscience and technology: a special feature on recent advances in hearing research
| ||||||||||||||
Yen-Fu Cheng. Frontiers in auditory bioscience and technology: a special feature on recent advances in hearing research[J]. Journal of Zhejiang University Science B, 2019, 20(2): 109-110.
@article{title="Frontiers in auditory bioscience and technology: a special feature on recent advances in hearing research",
author="Yen-Fu Cheng",
journal="Journal of Zhejiang University Science B",
volume="20",
number="2",
pages="109-110",
year="2019",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B1910001"
}
%0 Journal Article
%T Frontiers in auditory bioscience and technology: a special feature on recent advances in hearing research
%A Yen-Fu Cheng
%J Journal of Zhejiang University SCIENCE B
%V 20
%N 2
%P 109-110
%@ 1673-1581
%D 2019
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B1910001
TY - JOUR
T1 - Frontiers in auditory bioscience and technology: a special feature on recent advances in hearing research
A1 - Yen-Fu Cheng
J0 - Journal of Zhejiang University Science B
VL - 20
IS - 2
SP - 109
EP - 110
%@ 1673-1581
Y1 - 2019
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B1910001
Abstract: hearing impairment has become one of the most common sensory disabilities. The World Health Organization (WHO) estimates that 466 million people were living with disabling hearing loss in 2018, and that number could rise to 900 million by 2050. Conductive hearing loss, which predominantly involves the sound-transmitting route of the outer and middle ear, has been well handled by antibiotics and surgery. However, sensorineural hearing loss, which involves the inner ear and structures further within the auditory pathway, has very limited biological treatment options (current treatment options include only hearing amplification and cochlear implants). Part of the reason for the paucity of therapeutics is due to the complexity of the auditory system and the limited regenerative ability of the hearing sensory cells, hair cells, and connected nerve.
[1]Cheng YF, 2019. Atoh1 regulation in the cochlea: more than just transcription. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 20(2):146-155.
[2]Ma JY, You D, Li WY, et al., 2019. Bone morphogenetic proteins and inner ear development. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 20(2):131-145.
[3]Mizutari KJ, 2019. Blast-induced hearing loss. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 20(2):111-115.
[4]Peter N, Kleinjung TJ, 2019. Neuromodulation for tinnitus treatment: an overview of invasive and non-invasive techniques. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 20(2):116-130.
[5]Wang B, Dai WJ, Cheng XT, et al., 2019. Cerebrospinal fluid otorrhea secondary to congenital inner ear dysplasia: diagnosis and management of 18 cases. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 20(2):156-163.
[6]Zheng J, Meng W, Zhang C, et al., 2019. New SNP variants of MARVELD2 (DFNB49) associated with non-syndromic hearing loss in Chinese population. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 20(2):164-169.
ORCID: 
Open peer comments: Debate/Discuss/Question/Opinion
<1>